Company Profiles

driven by the PitchBook Platform

PharmaNeuroBoost

Description

Operator of bio pharmaceutical business intended to exploit the PNB01 and PNB02 opportunity for psychiatric disorders. The company's bio pharmaceutical business develops two anti-depression drugs PNB01 and PNB02, enabling treatment of depressive disorder and schizophrenia.

2006

Founded

OOB

Status

Liquidation

Latest Deal Type

$30.7M

Total Amount Raised

Description

Operator of bio pharmaceutical business intended to exploit the PNB01 and PNB02 opportunity for psychiatric disorders. The company's bio pharmaceutical business develops two anti-depression drugs PNB01 and PNB02, enabling treatment of depressive disorder and schizophrenia.

Website:

www.pharmaneuroboost.com

Ownership Status

Out of Business

Financing Status

Formerly PE-Backed

Primary Industry

Pharmaceuticals

Primary Office

Alkerstraat 30 A 3570 AlkenBelgium
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore PharmaNeuroBoost's full profile, request a free trial.

    PharmaNeuroBoost Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    PharmaNeuroBoost Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Erik Buntix MDFounder, Chief Executive Officer & Chief Scientific Officer
    Erik Buntix MD Founder, Chief Executive Officer & Chief Scientific Officer
    Request full access to PitchBook